Moreover, autologous T lymphocyte chimeric antigen receptor (CAR-T) cells against B7-H3 have been initiated phase I and II trials in both solid tumor and hematologic cancers 66. The gene discussed is CD276; the disease is hematopoietic and lymphoid cell neoplasm.